Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
04/05/202022h01PR Newswire (US)Insmed Announces Proposed Public Offering of Common StockNASDAQ:INSMInsmed Inc
30/04/202013h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
30/04/202013h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
30/04/202013h30PR Newswire (US)Insmed Reports First Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
23/04/202012h00PR Newswire (US)Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated TrialNASDAQ:INSMInsmed Inc
20/04/202014h00PR Newswire (US)Insmed to Host First Quarter 2020 Financial Results Conference Call on Thursday, April 30, 2020NASDAQ:INSMInsmed Inc
03/04/202014h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
02/04/202023h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
02/04/202023h46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
02/04/202014h00PR Newswire (US)Insmed Appoints Carol A. Schafer to its Board of DirectorsNASDAQ:INSMInsmed Inc
31/03/202015h06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
31/03/202015h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
27/03/202023h39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:INSMInsmed Inc
16/03/202022h36Dow Jones NewsInsmed: AstraZeneca Exercises Exclusive Option to Advance INS1007NASDAQ:INSMInsmed Inc
16/03/202021h01PR Newswire (US)Insmed Provides Business UpdateNASDAQ:INSMInsmed Inc
04/03/202014h00PR Newswire (US)Insmed Announces Publication Discussing the Clinical Management of Common Respiratory Events Associated with ARIKAYCE® (Amik...NASDAQ:INSMInsmed Inc
26/02/202014h00PR Newswire (US)Insmed to Present at the Cowen and Company 40th Annual Health Care ConferenceNASDAQ:INSMInsmed Inc
25/02/202013h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
25/02/202013h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
19/02/202014h00PR Newswire (US)Insmed to Present at the 9th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
14/02/202020h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
10/02/202014h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Tuesday, February 25, 2020NASDAQ:INSMInsmed Inc
03/02/202013h30PR Newswire (US)Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchie...NASDAQ:INSMInsmed Inc
30/01/202014h00PR Newswire (US)Insmed Appoints Sara Bonstein as Chief Financial OfficerNASDAQ:INSMInsmed Inc
09/01/202014h00PR Newswire (US)Insmed to Present at the 38th Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
26/11/201914h00PR Newswire (US)Insmed to Present at Two December ConferencesNASDAQ:INSMInsmed Inc
14/11/201914h00PR Newswire (US)Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating OfficerNASDAQ:INSMInsmed Inc
05/11/201914h00PR Newswire (US)Insmed to Present at Two November ConferencesNASDAQ:INSMInsmed Inc
30/10/201912h30PR Newswire (US)Insmed Reports Third Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
23/10/201914h00PR Newswire (US)Insmed to Host Third Quarter 2019 Financial Results Conference Call on Wednesday, October 30, 2019NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

Delayed Upgrade Clock